Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pivotal Trials For EU Approval Still Underrepresent Minorities, Study Finds

Roma, Europe’s Largest Minority, Not Represented At All

Executive Summary

Data on minority groups were frequently underreported, and in many cases numbers have not improved with time, according to the study by Tufts CSDD.

You may also be interested in...



Could The US FDA Set Clinical Trial Diversity Minimums?

Oncology Center of Excellence Director Richard Pazdur asked whether the FDA should have more conversations with sponsors about site selection and percentages of US participants.

How To Improve Diversity And Inclusion: Five Companies Share Best Practices

Company strategies at improving diversity, equity and inclusion both within their organizations and in the clinical trials they conduct have differed, but building trust is a common theme.

Sanofi Tries To ‘Bring More Of The Outside In’ For Diversity Efforts

The company is focusing first on gender parity as it navigates around tricky legal frameworks on collecting demographic data.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS146145

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel